TechPrecision Corporation (TPCS)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	47	22	32	61	58	37
Market Cap Growth	-29.86%	-29.86%	-47.97%	5.03%	54.76%	0.49%
Enterprise Value	59	34	44	74	72	40
Last Close Price	4.81	2.30	3.61	7.07	6.76	5.08
PE Ratio	-	-	-	-	-	116.84
Forward PE	-	6.50	6.50	6.50	6.50	6.50
PS Ratio	1.34	0.65	1.00	1.94	2.60	2.40
PB Ratio	5.37	2.54	4.06	4.17	3.80	3.77
P/TBV Ratio	5.38	2.54	4.06	4.17	3.80	3.77
P/FCF Ratio	-	-	-	74.95	-	2043.04
P/OCF Ratio	-	-	43.53	19.41	224.87	58.92
EV/Sales Ratio	1.72	1.00	1.39	2.35	3.23	2.57
EV/EBITDA Ratio	164.14	94.93	458.66	155.65	-	21.94
EV/EBIT Ratio	-	-	-	-	-	35.62
EV/FCF Ratio	-	-	-	90.71	-	2182.15
Debt / Equity Ratio	1.35	1.35	1.63	0.81	0.90	0.38
Debt / EBITDA Ratio	32.95	32.95	132.32	24.97	104.28	2.09
Debt / FCF Ratio	-	-	-	14.55	-	208.15
Asset Turnover	1.00	1.00	0.89	0.85	0.83	1.02
Inventory Turnover	9.69	9.69	9.70	11.42	10.79	9.75
Quick Ratio	0.71	0.71	0.62	1.31	1.02	1.75
Current Ratio	0.91	0.91	0.84	1.62	1.21	2.10
Return on Equity (ROE)	-33.22%	-33.22%	-62.88%	-6.56%	-2.78%	3.30%
Return on Assets (ROA)	-3.18%	-3.18%	-2.93%	-1.86%	-2.88%	4.59%
Return on Capital (ROIC)	-5.30%	-5.30%	-4.44%	-2.50%	-3.64%	5.44%
Return on Capital Employed (ROCE)	-	-	-	-	-	10.00%
Earnings Yield	-5.84%	-12.37%	-22.22%	-1.61%	-0.60%	0.86%
FCF Yield	-10.03%	-21.24%	-7.90%	1.33%	-1.18%	0.05%
Buyback Yield / Dilution	-8.51%	-8.51%	-1.41%	-6.19%	-4.33%	-6.07%

Updated Apr 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q